KRT222P inhibitors belong to a specialized class of chemical compounds designed to selectively modulate the activity of the Keratin 222 pseudogene (KRT222P). Pseudogenes, like KRT222P, are non-functional copies of protein-coding genes, and while they were traditionally considered genomic relics, emerging evidence suggests their potential involvement in diverse cellular processes. The inhibitors developed for KRT222P exhibit a specific chemical structure allowing them to interact selectively with defined binding sites on the KRT222P pseudogene, thereby influencing its molecular activities at the cellular level. The unique design of these inhibitors is crucial for ensuring a high degree of specificity, minimizing unintended effects on other genomic elements or cellular components.
The mechanism of action of KRT222P inhibitors involves disrupting the normal functioning of the KRT222P pseudogene, potentially impacting cellular processes associated with its regulatory role. Pseudogenes are intriguing entities that have garnered attention for their potential to influence gene expression, acting as regulators or decoys in cellular pathways. As researchers delve into the complexities of genomic regulation and the functional significance of pseudogenes, KRT222P inhibitors serve as valuable tools for investigating the precise molecular mechanisms governed by this particular genomic element. The study of this chemical class contributes to a deeper understanding of the role played by KRT222P in cellular physiology, offering insights into its potential functions within the intricate networks that regulate gene expression and genomic stability. Overall, the exploration of KRT222P inhibitors provides a platform for advancing our understanding of the molecular landscape surrounding pseudogenes and their nuanced roles in cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is an inhibitor of DNA methyltransferases, leading to reduced DNA methylation which can affect gene expression, possibly including KRT222P. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, which can alter chromatin structure and potentially downregulate genes like KRT222P. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-Amanitin is a potent inhibitor of RNA polymerase II, which can prevent mRNA synthesis and potentially decrease KRT222P expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during translation, which can lead to the reduction of protein levels, including KRT222P. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, leading to DNA damage and potentially affecting transcription and expression of various genes. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases (CDKs) and can suppress RNA polymerase II-mediated transcription, potentially reducing KRT222P expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB is an adenosine analog that inhibits CDK9 and can block RNA polymerase II activation, possibly affecting KRT222P expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to modulate epigenetic enzymes and could modify gene expression patterns, which may include the inhibition of KRT222P. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 is a histone deacetylase inhibitor, which can lead to chromatin remodeling and potentially alter the expression of genes like KRT222P. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a short-chain fatty acid that acts as a histone deacetylase inhibitor, potentially affecting gene expression, including KRT222P. | ||||||